Surgical Treatment of Gastric Cancer in a Community Hospital in Brazil: Who Are We Treating and How?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Surgical treatment of gastric cancer has risks, and the current trend in developed countries is to centralize cases in high-volume centers. Many countries, however, particularly the developing ones, have to rely in low-volume centers for the most part of gastric cancer operations. We aimed to verify the characteristics of the patients and tumors as well as the in-hospital outcomes in a community hospital in Brazil treating gastric cancer.
This is a retrospective study on patients undergoing surgical treatment of gastric adenocarcinoma at a community hospital in Brazil. The authors reviewed demographic, clinical, pathological, and perioperative data.
A total of 28 patients were operated on during the study period. Mean age was 69.5 years, 53.6 % were male, 67.9 % had anemia, 78.5 % had ASA score ≥ 3, 89.3 % were at nutritional risk, intestinal/diffuse ratio was 1.6, 68.5 % had tumor ≥ 6 cm, involvement of lower/middle third of the stomach occurred in 96.4 %, 73.7 % had serosal invasion, 79 % had stage III disease, median number of dissected nodes was 23, median operative time was 255 min, 21.4 % had urgent procedures, 67.8 % had curative surgery, 50 % had distal gastrectomy, 43.5 % had a Billroth I, median length of stay was 17 days, 53.6 % had some admission to the intensive care unit, 21.4 % required relaparotomy, 25 % had wound infection/dehiscence, and mortality was 66.7/18.2 % (urgent/non-urgent surgery).
We treat elderly malnourished patients with multiple comorbidities and advanced cancer. Improvement is required in lymph node dissection, non-surgical therapies, and critical care.
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300. CrossRef
- Instituto Nacional do Câncer—Ministério da Saúde do Brasil. Estimativas da incidência e mortalidade por câncer no Brasil—2012. http://www.inca.org.br. Accessed 15 January 2013
- Jacob CE, Bresciani C, Gama-Rodrigues JJ, et al. Behavior of gastric cancer in Brazilian population. ABCD Arq Bras Cir Dig. 2009;22:29–32. CrossRef
- Le A, Berger D, Lau M, El-Serag HB. Secular trends in the use, quality and outcomes of gastrectomy for noncardia gastric cancer in the United States. Ann Surg Oncol. 2007;14:2519–27. CrossRef
- Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010. Gastric Cancer. 2011;14:113–23. CrossRef
- Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117–27. CrossRef
- Smith JK, McPhee JT, Hill JS, et al. National outcomes after gastric resection for neoplasm. Arch Surg. 2007;142:387–93. CrossRef
- Japanese Gastric Cancer Association. Guidelines for diagnosis and treatment of carcinoma of the stomach, 2004 edition. www.jgca.jp/pdf/Guidelines2004_eng.pdf. Accessed 15 January 2013
- Fitz-Henry J. The ASA, classification and peri-operative risk. Ann R Coll Surg Engl. 2011;93:185–87. CrossRef
- Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415–21. CrossRef
- Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 1965;64:31–49.
- Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12. CrossRef
- Sb E, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2009.
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13. CrossRef
- Reavis KM, Hinojosa MW, Smith BR, et al. Hospital volume is not a predictor of outcomes after gastrectomy for neoplasm. Am Surg. 2009;75:932–6.
- Novotny AR, Schuhmacher C, Busch R, et al. Predicting individual survival after gastric cancer resection validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg. 2006;243:74–81. CrossRef
- Ahn HS, Yook JH, Park CH, et al. General perioperative management of gastric cancer patients at high-volume centers. Gastric Cancer. 2011;14:178–82. CrossRef
- Allum WH, Griffin SM, Watson A, Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut. 2002;50 Suppl 5:v1–23. CrossRef
- Reid-Lombardo KM, Gay G, Patel-Parekh L, et al. Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from the National Cancer Data Base. J Gastrointest Surg. 2007;11:410–20. CrossRef
- Lin HC, Xirasagar S, Lee HC, Chai CY. Hospital volume and inpatient mortality after cancer-related gastrointestinal resections: the experience of an Asian country. Ann Surg Oncol. 2006;13:1182–8. CrossRef
- Hannan EL, Radzyner M, Rubin D, et al. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery. 2002;131:6–15. CrossRef
- Kim M, Park J, Kim SG, et al. Feasibility of gastric cancer surgery at low volume hospitals. J Gastric Cancer. 2010;10:234–40. CrossRef
- Damhuis RA, Meurs CJ, Dijkhuis CM, et al. T. Hospital volume and post-operative mortality after resection for gastric cancer. Eur J Surg Oncol. 2002;28:401–5. CrossRef
- Thompson AM, Rapson Y, Gilbert FJ, Park KGM. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg. 2007;94:578–84. CrossRef
- Callahan MA, Christos PJ, Gold HT, et al. Influence of surgical subspecialty training on hospital mortality for gastrectomy and colectomy. Ann Surg. 2003;238:629–36.
- Jang YJ, Park MS, Park SS, et al. Surgeon subspecialty as a factor in improving long-term outcomes for gastric cancer: twenty years of experience in Korea. Arch Surg. 2010;145:1091–6. CrossRef
- Dicken BJ, Saunders LD, Jhangri GS, et al. Gastric cancer: establishing predictors of behavior with use of population-based data. Ann Surg Oncol. 2004;11:629–35. CrossRef
- Hyung WJ, Kim SS, Choi WH, et al. Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution. Yonsei Med J. 2008;49:409–15. CrossRef
- Sharma A, Radhakrishnan V. Gastric cancer in India. Indian J Med Paediatr Oncol. 2011;32:12–6. CrossRef
- Mohri Y, Tonouchi H, Miki C, et al. Incidence and risk factors for hospital-acquired pneumonia after surgery for gastric cancer. World J Surg. 2008;32:1045–50. CrossRef
- Jaworski R, Bollschweiler E, Holscher AH, et al. Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany. Gastric Cancer. 2011;14:234–41. CrossRef
- Aronson WL, McAuliffe MS, Miller K. Variability in the American Society of Anesthesiologists physical status classification scale. AANA J. 2003;71:265–74.
- Mariette C, De Botton ML, Piessen G. Surgery in esophageal and gastric cancer patients: what is the role for nutrition support in your daily practice? Ann Surg Oncol. 2012;19:2128–34. CrossRef
- Watanabe M, Iwatsuki M, Iwagami S, et al. Prognostic nutritional index predicts outcomes of gastrectomy in the elderly. World J Surg. 2012;36:1632–39. CrossRef
- Oh CA, Kim DH, Oh SJ, et al. Nutritional risk index as a predictor of postoperative wound complications after gastrectomy. World J Gastroenterol. 2012;18:673–78. CrossRef
- Lemes L, Neunschwander LC, Matta LAC, et al. Gastric carcinoma: analysis of 289 gastrectomy specimens in Brazil J Bras Patol. Med Lab. 2003;39:57–65.
- Rampazzo A, Motta GL, Fontana K, Fagundes RB. Gastric adenocarcinoma trends in the central region of Rio Grande do Sul (southern Brazil): what has changed in 25 years? Arq Gastroenterol. 2012;49:179–83. CrossRef
- Lourenço LG, Hamada G. Gastric cancer in Brazil. Gastric Cancer. 2001;4:103–5. CrossRef
- Henson DE, Dittus C, Younes M, et al. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128:765–70.
- Hsu PK, Huang HC, Hsieh CC, et al. Effect of formalin fixation on tumor size determination in non-small cell lung cancer. Ann Thorac Surg. 2007;84:1825–9. CrossRef
- Liu X, Xu Y, Long Z, et al. Prognostic significance of tumor size in T3 gastric cancer. Ann Surg Oncol. 2009;16:1875–82. CrossRef
- Im WJ, Kim MG, Ha TK, Kwon SJ. Tumor size as a prognostic factor in gastric cancer patient. J Gastric Cancer. 2012;12:164–72. CrossRef
- Son T, Hyung WJ, Lee JH, et al. Clinical implication of an insufficient number of lymph nodes after curative resection for gastric cancer. Cancer. 2012;118:4687–93. CrossRef
- Karpeh M, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than number? Ann Surg. 2000;232:362–71. CrossRef
- Seevaratnam R, Bocicariu A, Cardoso R, et al. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15 Suppl 1:S60–9. CrossRef
- Pinto CE, Filho OS, Correa JHS, et al. D2 gastrectomy: a study of related morbidity and mortality. Rev Bras Cancerol. 2001;47:397–401.
- Ikeguchi M, Oka S, Gomyo Y, et al. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer. Anticancer Res. 2000;20:1285–9.
- Msika S, Benhamiche AM, Jouve JL, et al. Prognostic factors after curative resection for gastric cancer. A population study. Eur J Cancer. 2000;36:390–6. CrossRef
- Piessen G, Triboulet JP, Mariette C. Reconstruction after gastrectomy: which technique is best? J Visc Surg. 2010;147:273–83. CrossRef
- Inokuchi M, Kojima K, Yamada H, et al. Long-term outcomes of Roux-en-Y and B-I reconstruction after laparoscopic distal gastrectomy. Gastric Cancer. 2013;16:67–73. CrossRef
- Kim TG, Hur H, Ahn CW, et al. Efficacy of Roux-en-Y reconstruction using two circular staplers after subtotal gastrectomy: results from a pilot study comparing with Billroth-I reconstruction. J Gastric Cancer. 2011;11:219–24. CrossRef
- Imamura H, Takiguchi S, Yamamoto K, et al. Morbidity and mortality results from a prospective randomized controlled trial comparing Billroth I and Roux-en-Y reconstructive procedures after distal gastrectomy for gastric cancer. World J Surg. 2012;36:632–7. CrossRef
- Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity in D1 and D2 dissection for gastric cancer in Dutch patients. Lancet. 1995;25:745–8. CrossRef
- Kuwabara K, Matsuda S, Fushimi K, et al. Comparative study on the difference in functional outcomes at discharge between proximal and total gastrectomy. Case Rep Gastroenterol. 2012;6:400–9. CrossRef
- Chrusch CA, Olafson KP, Mcmillan PM. High occupancy increases risk of early death or readmission after transfer from intensive care. Crit Care Med. 2009;37:1–6. CrossRef
- Kim KM, An JY, Kim HI, et al. Major early complications following open, laparoscopic and robotic gastrectomy. Br J Surg. 2012;99:1681–7. CrossRef
- Oh SJ, Choi WB, Song J, et al. Complications requiring reoperation after gastrectomy for gastric cancer. J Gastrointest Surg. 2009;13:239–45. CrossRef
- Li Z, Jie Z, Liu Y, Xie X. Management of delayed hemorrhage following radical gastrectomy for gastric carcinoma. Hepatogastroenterology. 2012;59:2016–9. CrossRef
- Hanna GB, Boshier PR, Knaggs A, et al. Improving outcomes after gastroesophageal cancer resection: can Japanese results be reproduced in Western centers? Arch Surg. 2012;147:738–45. CrossRef
- Jeong O, Ryu SY, Zhao XF, et al. Short-term surgical outcomes and operative risks of laparoscopic total gastrectomy (LTG) for gastric carcinoma: experience at a large-volume center. Surg Endosc. 2012;26:3418–25. CrossRef
- Nobuoka D, Gotohda N, Konishi M, et al. Prevention of postoperative pancreatic fistula after total gastrectomy. World J Surg. 2008;32:2261–6. CrossRef
- Miki Y, Tokunaga M, Bando E, et al. Evaluation of postoperative pancreatic fistula after total gastrectomy with lymphadenectomy. J Gastrointest Surg. 2011;15:1969–76. CrossRef
- Tomimaru Y, Miyashiro I, Kishi K, et al. Is routine measurement of amylase concentration in drainage fluid necessary after total gastrectomy for gastric cancer. J Surg Oncol. 2011;104:274–7. CrossRef
- Kunisaki C, Makino H, Suwa H, et al. Impact of splenectomy in patients with gastric adenocarcinoma of the cardia. J Gastrointest Surg. 2007;11:1039–44. CrossRef
- Herbella FA, Tineli AC, Wilson JL. Gastrectomy and lymphadenectomy for gastric cancer: is the pancreas safe? J Gastrointest Surg. 2008;12:1912–4. CrossRef
- Lo CH, Chen JH, Wu CW, et al. Risk factors and management of intra-abdominal infection after extended radical gastrectomy. Am J Surg. 2008;196:741–5. CrossRef
- Fedeli U, Schievano E, Lisiero M. Mortality after esophageal and gastric cancer resection. World J Surg. 2012;36:2630–6. CrossRef
- Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet. 1996;347:995–9. CrossRef
- Guadagni S, Catarci M, Kinoshita T, et al. Causes of death and recurrence after surgery for early gastric cancer. World J Surg. 1997;21:434–39. CrossRef
- Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–62. CrossRef
- Hayashi T, Yoshikawa T, Aoyama T, et al. A. Severity of complications after gastrectomy in elderly patients with gastric cancer. World J Surg. 2012;36:2139–45. CrossRef
- Surgical Treatment of Gastric Cancer in a Community Hospital in Brazil: Who Are We Treating and How?
Journal of Gastrointestinal Cancer
Volume 44, Issue 4 , pp 410-416
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Gastric surgery
- Gastric adenocarcinoma
- Outcome assessment
- Community health planning
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Unacon-Betim, Av. Edmeia Lazarotti, 3800, Betim, Brazil
- 3. Rua Gonçalves Dias 332/1001, 30140-090, Belo Horizonte, Brazil
- 2. School of Medicine, Federal University of São Paulo, São Paulo, Brazil